These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 18639341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [Abstract] [Full Text] [Related]

  • 4. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.
    Huttunen R, Syrjänen J, Aittoniemi J, Oja SS, Raitala A, Laine J, Pertovaara M, Vuento R, Huhtala H, Hurme M.
    Shock; 2010 Feb; 33(2):149-54. PubMed ID: 19487973
    [Abstract] [Full Text] [Related]

  • 5. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.
    Pertovaara M, Raitala A, Lehtimäki T, Karhunen PJ, Oja SS, Jylhä M, Hervonen A, Hurme M.
    Mech Ageing Dev; 2006 May; 127(5):497-9. PubMed ID: 16513157
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers.
    Sperner-Unterweger B, Neurauter G, Klieber M, Kurz K, Meraner V, Zeimet A, Fuchs D.
    Immunobiology; 2011 Mar; 216(3):296-301. PubMed ID: 20822828
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome.
    Pertovaara M, Raitala A, Uusitalo H, Pukander J, Helin H, Oja SS, Hurme M.
    Clin Exp Immunol; 2005 Oct; 142(1):155-61. PubMed ID: 16178870
    [Abstract] [Full Text] [Related]

  • 13. [Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer].
    Sakurai K, Matsuo S, Enomoto K, Tani M, Kitajima A, Amano S.
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1991-3. PubMed ID: 20037301
    [Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms.
    Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M.
    Mol Immunol; 2007 Feb; 44(5):1011-4. PubMed ID: 16620985
    [Abstract] [Full Text] [Related]

  • 15. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M.
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [Abstract] [Full Text] [Related]

  • 16. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy.
    Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M.
    Mol Immunol; 2006 Mar; 43(7):1054-6. PubMed ID: 15992929
    [Abstract] [Full Text] [Related]

  • 17. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.
    Brandacher G, Cakar F, Winkler C, Schneeberger S, Obrist P, Bösmüller C, Werner-Felmayer G, Werner ER, Bonatti H, Margreiter R, Fuchs D.
    Kidney Int; 2007 Jan; 71(1):60-7. PubMed ID: 17136028
    [Abstract] [Full Text] [Related]

  • 18. [Indoleamine 2,3-dioxygenase expression in breast cancer patients during chemotherapy].
    Sakurai K, Enomoto K, Kitajima A, Tani M, Amano S, Shiono M.
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2265-7. PubMed ID: 19106591
    [Abstract] [Full Text] [Related]

  • 19. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients.
    Weinlich G, Murr C, Richardsen L, Winkler C, Fuchs D.
    Dermatology; 2007 Nov; 214(1):8-14. PubMed ID: 17191041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.